Summary:

We are seeking a scientifically driven and communicative Medical Science Liaison (MSL) to join our Medical Affairs team. The Medical Science Liaison (MSL) serves as a scientific expert in immunization and pneumococcal disease prevention. This field-based role will serve as a trusted scientific partner to healthcare providers, public health officials, and key opinion leaders (KOLs) to support vaccine education, clinical development, and real-world evidence generation.  

Depending on experience, the role may be leveled at Senior MSL, offering expanded responsibilities in strategic leadership and mentorship. 

Essential Functions:

• Stakeholder Management: Build and maintain scientific relationships with key opinion leaders, clinicians, researchers, and public health stakeholders.
• Scientific Engagement: Communicate epidemiological, clinical and real-world data regarding pneumococcal disease and Vaxcyte’s candidate vaccine.
• Evidence Generation Support: Where relevant, support investigator-initiated studies and clinical trial recruitment in vaccine research.
• Insight Collection and cross-functional collaboration: Gather and share field insights on pneumococcal disease landscape, vaccine data needs, and recommendation scenarios.
• Education and Engagement: Represent the company at scientific meetings, conferences, and stakeholder events.
• Compliance: Uphold ethical standards and regulatory guidelines in all field activities. 

Requirements: 

• Advanced degree (PhD, PharmD, MD, MPH) in life sciences, immunology, or public health preferred.
• A minimum of 5 years of experience in medical affairs, clinical research, or infectious disease.
• Strong knowledge of immunology and vaccine development.
• Excellent communication skills with ability to address scientific and public health audiences.
• Travel: MSL positions are field-based and require significant travel, which can vary depending on the assigned territory.  
• Ability to travel up to 70% of the time.
• Other combinations of education and/or experience may be considered.